The store will not work correctly when cookies are disabled.
5'-cyclobutyl-3'H-spiro[cyclohexane-1,1'-furo[3,4-c]pyridine]-3',4'(5'H)-dione
ID: ALA4741980
PubChem CID: 162645494
Max Phase: Preclinical
Molecular Formula: C16H19NO3
Molecular Weight: 273.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1OC2(CCCCC2)c2ccn(C3CCC3)c(=O)c21
Standard InChI: InChI=1S/C16H19NO3/c18-14-13-12(7-10-17(14)11-5-4-6-11)16(20-15(13)19)8-2-1-3-9-16/h7,10-11H,1-6,8-9H2
Standard InChI Key: KEAYLWILXJHIQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
4.1685 -6.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3513 -6.1702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9414 -6.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3442 -7.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1614 -7.5864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5758 -6.8802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6538 -6.3270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3591 -5.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6538 -4.6927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6538 -3.8755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9485 -5.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9486 -5.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1714 -4.8528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6910 -5.5139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9190 -4.0756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3621 -5.1037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0710 -4.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8634 -4.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0772 -4.1245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2885 -3.9107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
12 9 1 0
11 7 1 0
7 8 2 0
8 16 1 0
16 9 1 0
9 10 2 0
11 12 2 0
12 13 1 0
13 14 1 0
14 1 1 0
1 11 1 0
13 15 2 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.33 | Molecular Weight (Monoisotopic): 273.1365 | AlogP: 2.90 | #Rotatable Bonds: 1 |
Polar Surface Area: 48.30 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.32 | CX LogD: 2.32 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.74 | Np Likeness Score: 0.32 |
References
1. Hayek S,Pietrancosta N,Hovhannisyan AA,Alves de Sousa R,Bekaddour N,Ermellino L,Tramontano E,Arnould S,Sardet C,Dairou J,Diaz O,Lotteau V,Nisole S,Melikyan G,Herbeuval JP,Vidalain PO. (2020) Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition., 186 [PMID:31740051] [10.1016/j.ejmech.2019.111855] |